7 weeks ago.
ASX ANNOUNCEMENT 1 August 2016
Cynata Files Application to Commence Phase 1 Clinical Trial
“The application to commence our Phase 1 study with the MHRA represents the culmination of an intensive program of manufacturing process development, safety evaluation and proof-of-concept studies. The successful outcomes from our product development activities over the past two-and-a- half years have allowed us to move things forward,” said Cynata Vice President of Product Development, Dr Kilian Kelly. “We have been very pleased with the result of our pre-clinical program and are eager to advance to an initial clinical study with our induced pluripotent stem cell (iPSC) derived MSC therapeutic product, CYP-001.”
All Positive.
7 weeks ago. ASX ANNOUNCEMENT 1 August 2016 Cynata Files...
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
0.005(2.38%) |
Mkt cap ! $38.84M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 22.0¢ | 20.5¢ | $11.17K | 53.85K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6162 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 13800 | 1 |
View Market Depth
| Last trade - 14.25pm 30/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |